Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1-3 newly diagnosed brain metastases.
Ahluwalia MS, Chao ST, Parsons MW, Suh JH, Wang D, Mikkelsen T, Brewer CJ, Smolenski KN, Schilero C, Rump M, Elson P, Angelov L, Barnett GH, Vogelbaum MA, Weil RJ, Peereboom DM.
Ahluwalia MS, et al.
J Neurooncol. 2015 Sep;124(3):485-91. doi: 10.1007/s11060-015-1862-6. Epub 2015 Aug 6.
J Neurooncol. 2015.
PMID: 26245136
Clinical Trial.